[
    {
        "title": "Tiziana Life Sciences Initiates Multi-Center Phase 2a Clinical Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple Sclerosis - Yahoo Finance",
        "description": "Tiziana Life Sciences Initiates Multi-Center Phase 2a Clinical Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple Sclerosis  Yahoo Finance",
        "published date": "Tue, 26 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90aXppYW5hLWxpZmUtc2NpZW5jZXMtaW5pdGlhdGVzLW11bHRpLTExMDAwMDYxNC5odG1s0gFbaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvdGl6aWFuYS1saWZlLXNjaWVuY2VzLWluaXRpYXRlcy1tdWx0aS0xMTAwMDA2MTQuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]